Search form

Sections

Carl Elliott

The Markingson Files: Heads start to roll as clinical trial suicide revelations mount

The University of Minnesota is replacing the chairman of its psychiatry department following two scathing reviews of its safety protocols in research involving human subjects and its recruitment of a troubled man who later died by suicide in a schizophrenia drug trial.

Slap: American Journal of Bioethics Goes On Offense During Painkiller Inquiry

Antidote has received some disturbing communications from a bioethics journal we reported on. Read on for the back story.

Q&A with Leigh Turner, Part 3: Celltex Tries to Intimidate a Whistleblower

Bioethicist Leigh Turner describes how the stem cell company Celltex tried to intimidate him and his university when he asked the FDA to investigate the company.

Q&A with Leigh Turner, Part 2: Finding Ethical Quandaries Amid Academic Rivalries

Bioethicist Leigh Turner talks about why he sicced the FDA on Celltex and about academic rivalries in the world of bioethics.

Q&A with Leigh Turner: Tracking Medical Tourism Consequences

Bioethicist Leigh Turner, recently under fire from a stem cell company he criticized for ethical problems, talks about his research on medical tourism.

Slap: Celltex Threatens University of Minnesota For Ethicist's FDA Letter

When controversial bioethicist Glenn McGee quit his job as chief ethics advisor to Houston-based Celltex Therapeutics in February, the controversy over the company was on the verge of dying down. Until Celltex threatened a major public university and the very concept of free speech.

Slap: Pressure From Politically-Connected Stem Cell Firm Celltex Leads To Slate Retraction

Why did Slate retract a critical commentary by bioethicist Carl Elliott on stem cell firm Celltex after a demand by the controversial company's CEO?

The Markingson Files: Court leaves key questions in clinical trial suicide unanswered

Any investigative reporter will tell you that a case dismissal does not necessarily mean a victory. Here's how that rule of thumb figures into the case of Dan Markingson, who committed suicide after participating in a clinical trial for the psychiatric drug Seroquel.

The Markingson Files: University of Minnesota dallies on clinical trial documentation

A candid email from a university publicist sheds some, but not enough, light on why the university won't provide documents from a controversial Seroquel clinical study.

The Markingson Files: Conflicts of interest in clinical trials should be transparent

It can be uncomfortable asking people about their finances. In journalism, though, there is an obligation not only to ask, but to ask for proof — especially with clinical trials.

Pages

Announcements

Thanks to groundbreaking new research, we can now see how much private insurance plans are paying for common procedures and per person in communities across the U.S. This webinar will help journalists and policy makers contextualize the private-payer data, discuss possible policy responses, and offer suggestions for how reporters can use this resource to bolster their reporting. Register here.

Interested in learning more about the health, education and social challenges children face as a result of poverty and adversity?  Apply now for the 2016 National Health Journalism Fellowship, which comes with $2,000-$10,000 reporting grant, five days of intensive all-expenses-paid traing in L.A., and six months of mentoring. Details here.

CONNECT WITH THE COMMUNITY

Member Activities

Patricia Wight has shared a fellowship project

Read it.

Leila Day has shared a blog post

Read it.

Angela Hart has shared a fellowship project

Read it.

David Moskowitz MD's profile has been updated

Connect with David Moskowitz MD

William Heisel has shared a blog post

Read it.
More Member Activities

Follow Us

ReportingHealth